Treating and Managing MS with Kesimpta®▼
Novartis MS Meeting featuring
Dr. Wallace Brownlee, National Hospital for Neurology & Neurosurgery, London
Saturday 19th November 2022
This site is intended for healthcare professionals registered within the Republic of Ireland. If you are a member of the public, please click here.
Novartis MS Meeting featuring
Dr. Wallace Brownlee, National Hospital for Neurology & Neurosurgery, London
Saturday 19th November 2022
Reporting of side effects
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk profile of the medicinal product. All suspected adverse reactions should be reported to HPRA Pharmacovigilance, website www.hpra.ie. Adverse events can also be reported to Novartis preferably at www.novartis.com/report, by emailing [email protected] or by calling (01) 2080 612.